Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05788757 · ClinicalTrials.gov registry record
Optetrak Knee System Post Market Clinical Follow-Up
A clinical trial of Knee Arthroplasty, Total, sponsored by Exactech.
- Active
- Registry status
- 4,588
- Enrollment target
- 3
- Study locations
NCT05788757 is a study of Knee Arthroplasty, Total that is active but no longer recruiting, run by Exactech. The registered enrollment target is 4,588 participants, above the 389-participant average among 3 other Knee Arthroplasty, Total trials with a reported enrollment target (1079% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT05788757, a study of Knee Arthroplasty, Total, is active but no longer recruiting, sponsored by Exactech.
- ACTIVE NOT RECRUITING
- Registry status
- 4,588 participants
- Enrollment target
- 3
- Study locations
Study Summary
A Post-Market Domestic (US) and International Data Collection to Assess the Optetrak Knee System
Conditions Studied
Interventions
- DEVICE Optetrak Total Knee System
Study Locations (3)
Massachusetts
- Fallon Clinic - Worcester
Nevada
- Nevada Orthopaedic and Spine Center - Las Vegas
South Carolina
- Medical University South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,588 participants |
| Start Date | 2011-06-01 |
| Est. Completion | 2034-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05788757
The ClinicalTrials.gov registry entry for NCT05788757 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 4,588 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 389-participant average among 3 other Knee Arthroplasty, Total trials with a reported enrollment target (1079% higher). The listed sponsor is Exactech, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Knee Arthroplasty, Total appearing as the primary indexed condition, and to 1 intervention - of which Optetrak Total Knee System is the first listed.
NCT05788757 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Nevada, South Carolina.
Frequently Asked Questions
What is clinical trial NCT05788757 about?
NCT05788757 is a clinical study titled "Optetrak Knee System Post Market Clinical Follow-Up". A Post-Market Domestic (US) and International Data Collection to Assess the Optetrak Knee System
What is the current status of trial NCT05788757?
This trial is currently active not recruiting. The enrollment target is 4,588 participants. The study started on 2011-06-01. Estimated completion is 2034-06-01.
What conditions does trial NCT05788757 study?
This clinical trial studies the following conditions: Knee Arthroplasty, Total.
What interventions are being tested in trial NCT05788757?
The interventions under investigation include: Optetrak Total Knee System (DEVICE).
Who is sponsoring clinical trial NCT05788757?
This trial is sponsored by Exactech, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05788757 being conducted?
This trial has 3 study locations across Massachusetts, Nevada, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Arthroplasty, Total
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.